title: Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation.
authors.forename: P
authors.initials: P
authors.lastname: Prandoni
authors.forename: D
authors.initials: D
authors.lastname: Tormene
authors.forename: L
authors.initials: L
authors.lastname: Spiezia
authors.forename: R
authors.initials: R
authors.lastname: Pesavento
authors.forename: P
authors.initials: P
authors.lastname: Simioni
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D005165:Factor V / Q000235:genetics*; D005500:Follow-Up Studies; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D011516:Prothrombin / Q000235:genetics*; D055502:Secondary Prevention; D013923:Thromboembolism / Q000188:drug therapy* / Q000473:pathology; D055815:Young Adult
chemical_list: D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin